Found 13 matching trials
Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma PHASE2 Background:
Advanced urothelial cancer has no cure. But only a few chemoth...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Dose Escalation of Clofarabine in Combination With Cytarabine and Idarubicin as Induction Therapy in High Risk AML PHASE1 With current chemotherapy protocols, in 60-80% of patients with acute myelo...
Show More Location
Universitätsklinikum Düsseldorf
Learn More & Join Trial
Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia PHASE3 The primary objective of this study is to demonstrate the efficacy of Iomab...
Show More Status
Active Not Recruiting
Location
Banner MD Anderson Cancer Center
Learn More & Join Trial
Clofarabine, Cytarabine, and Idarubicin in Treating Patients With Intermediate-Risk or High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplasia PHASE1 RATIONALE: Drugs used in chemotherapy, such as clofarabine, cytarabine, and...
Show More Learn More & Join Trial
Clofarabine, Idarubicin, and Cytarabine Combination in Acute Myeloid Leukemia (AML) Induction PHASE2 The goal of this clinical research study is to learn if the combination of ...
Show More Location
UT MD Anderson Cancer Center
Learn More & Join Trial
Study Evaluating the Efficacy of 90Yttrium-epratuzumab in Adults With CD22+ Relapsed/Refractory B-ALL PHASE2 The investigators propose a randomized phase 2 study evaluating 90Y-epratuz...
Show More Location
CHU de Clermont-Ferrand
Learn More & Join Trial
Clofarabine Combinations in Relapsed/Refractory Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS) and Myeloid Blast Phase Chronic Myeloid Leukemia (CML) PHASE2 The goal is to compare the drug combinations clofarabine/idarubicin/ara-C, ...
Show More Location
UT MD Anderson Cancer Center
Learn More & Join Trial
Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML) PHASE2 Objectives:
Primary Objectives:
1. To determine the safety and feasibilit...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial
Clofarabine, Idarubicin, and Cytarabine (CIA) Versus Fludarabine, Idarubicin, and Cytarabine (FLAI) in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome PHASE1 The goal of this clinical research study is to learn if the combination of ...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial
Decitabine Followed by Clofarabine, Idarubicin, and Cytarabine in Acute Leukemia PHASE1 The goal of Phase I of this clinical research study is find the highest tol...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial